Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Feb 15, 2013 (Vol. 33, No. 4)

FLIGHT

URL:flight.icr.ac.uk
  • Nice organization, especially on “browse” page; many datasets
  • No longer updated—most recent studies are from 2010

Do you work with Drosophila? Are you planning any RNAi experiments? If you answered “yes” to those questions, then I have a website that may really help your project take “FLIGHT.” FLIGHT, developed by a group at the Institute of Cancer Research in the U.K., is a website that brings together data from both in vivo and in vitro RNAi screens in Drosophila. Containing more than 100 datasets, the site allows users to browse or search the compiled information, and also offers the option for users to upload and analyze their own datasets. The “browse” page is conveniently organized, giving a topic heading to each project (such as “neural development”), the PubMed link to the original publication, and the ability to view the hits from the RNAi screen within the browser.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »